Latest updates
A lot is happening!
May, 2020
We are thrilled to inform you that we launched our ixcyte cell line development.
Jan, 2020
BioIVT is appointed as a worldwide distributor of upcyte® products for use in in-vitro drug discovery and development studies. This new partnership will increase the visibility of upcyte® cells in the worldwide research market. We are excited about this relationship!
Nov, 2019
upcyte is very pleased, that the investment and development bank Hamburg granted the latest research project. Together with acCELLerate, we are aiming to immortalize primary adipocytes and to develope an innovative cryopreservation protocol to prepare assay ready cells. Assay ready upcyte adipocytes, would be tremendously beneficial for diabetes or cancer research, which are intimately connected with adiposity.